| 000 | 01347 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515040920.0 | ||
| 264 | 0 | _c20060928 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a1699-048X | ||
| 024 | 7 |
_a10.1007/s12094-006-0063-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBueno Muíño, Coralia | |
| 245 | 0 | 0 |
_aNew target-based agents involve new clinical trial designs. _h[electronic resource] |
| 260 |
_bClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _cAug 2006 |
||
| 300 |
_a581-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 700 | 1 | _aGarcía-Sáenz, José Angel | |
| 700 | 1 | _aLópez Tarruella, Sara | |
| 700 | 1 | _aRodríguez Lajustica, Laura | |
| 700 | 1 | _aDíaz-Rubio, Eduardo | |
| 773 | 0 |
_tClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _gvol. 8 _gno. 8 _gp. 581-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12094-006-0063-3 _zAvailable from publisher's website |
| 999 |
_c16536714 _d16536714 |
||